PCNA, BRCA1 and XPB displayed a lack of induction and highly correlated with altered expression in melanoma after cisplatin treatment by GSEA, therefore they were further investigated in 157 primary and metastatic melanoma tumours. The gene discussed is BRCA1; the disease is melanoma.